News
ASXC
0.2506
+0.24%
0.0006
Weekly Report: what happened at ASXC last week (0415-0419)?
Weekly Report · 1d ago
Weekly Report: what happened at ASXC last week (0408-0412)?
Weekly Report · 04/15 11:49
Weekly Report: what happened at ASXC last week (0401-0405)?
Weekly Report · 04/08 11:55
Wayfair To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Thursday
Goldman Sachs boosted the price target for Avis Budget Group, Inc. HSBC slashed Chubb Limited's price target from $275 to $270 on Wednesday. Evercore ISI Group increased the price targets for Wayfair and Signet Jewelers. Asensus Surgical shares jumped 33.6% to close at $0.35. Telsey Advisory Group raised the price of Levi Strauss & Co.
Benzinga · 04/04 11:40
Asensus Surgical Cut to Neutral From Buy by HC Wainwright & Co.
Dow Jones · 04/04 10:17
Asensus Surgical Price Target Cut to $0.35/Share From $2.00 by HC Wainwright & Co.
Dow Jones · 04/04 10:17
HC Wainwright & Co. Downgrades Asensus Surgical to Neutral, Lowers Price Target to $0.35
Benzinga · 04/04 10:06
ASENSUS SURGICAL, INC. <ASXC.A>: H.C. WAINWRIGHT CUTS TO NEUTRAL FROM BUY
Reuters · 04/04 10:03
Asensus Surgical Agrees To Karl Storz's Acquisition Offer; Stock Up
NASDAQ · 04/03 14:14
Asensus Surgical gains after Germany-based KARL STORZ announces buyout bid
Asensus Surgical signed a non-binding letter of intent with Germany-based KARL STORZ SE & Co. To acquire Asensus for $0.35 per share in cash. The deal represents a 66.7% premium to Asensus' closing price on April 2.
Seeking Alpha · 04/03 13:17
Asensus Surgical Agrees to Enter Diligence After Takeover Offer
Asensus Surgical says Karl Storz has offered to buy Asensus for 35 cents a share. The offer is a 67% premium to Asensus's closing price on Tuesday. Asensus says it has entered into a non-binding letter of intent to negotiate a takeover offer.
Dow Jones · 04/03 13:16
ASENSUS SURGICAL INC: IF MERGER AGREEMENT IS SUCCESSFULLY NEGOTIATED & EXECUTED, ADDITIONAL FUNDING OF UP TO $10 MLN TO BE AVAILABLE UNDER BRIDGE LOAN
Reuters · 04/03 12:45
Press Release: Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG
Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG KARl STORZ to provide up to $20 million in bridge financing. Asensus is a medical device company that is digitizing the interface between the surgeon and the patient.
Dow Jones · 04/03 12:45
Press Release: Asensus Surgical, Inc. Announces -2-
Asensus and its directors and executive officers may be deemed participants in the solicitation of proxies from stockholders in connection with the proposed transaction. Security holders are urged to read the definitive proxy statement and other documents. This press release is not a solicitation to support or oppose the proposed deal.
Dow Jones · 04/03 12:45
Weekly Report: what happened at ASXC last week (0325-0329)?
Weekly Report · 04/01 11:52
Weekly Report: what happened at ASXC last week (0318-0322)?
Weekly Report · 03/25 11:55
Asensus Surgical Price Target Maintained With a $2.00/Share by HC Wainwright & Co.
Dow Jones · 03/22 15:13
Asensus Surgical Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 03/22 15:13
HC Wainwright & Co. Maintains Buy on Asensus Surgical, Maintains $2 Price Target
Benzinga · 03/22 15:02
Buy Rating Affirmed on Asensus Surgical Amidst Growth and Expansion Prospects
TipRanks · 03/22 12:45
More
Webull provides a variety of real-time ASXC stock news. You can receive the latest news about Asensus Surgical Inc through multiple platforms. This information may help you make smarter investment decisions.
About ASXC
Asensus Surgical, Inc. is a medical device company digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery to enable surgeons to deliver outcomes to patients and establish a new standard of surgery. It operates in one business segment, which is the research, development and sale of medical device robotics to improve minimally invasive surgery. It is developing the LUNA Surgical System, a robotic and instrument system as a foundation of its Digital Surgery solution. These systems shall be powered by the Intelligent Surgical Unit to enhance surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, it intends to holistically address the clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. It is also working to incorporate all of this in the LUNA Surgical System.